Loading…
This event has ended. Visit the official site or create your own event on Sched.
SYMPOSIUM THEME
Hemoglobin S - Making an Evolutionary Perfected Process, Imperfect 

Journal of Sickle Cell Disease and Hemoglobinoopathies
SYMPOSIUM ABSTRACTS

Meeting Location:

Greater Ft. Lauderdale Convention Center
1950 Eisenhower Blvd, Fort Lauderdale, Florida, USA  33316
April 28 - 30, 2017 
Website:  fscdr.org
Email:  symposium@fscdr.org
Is this a CME Medical Meeting?  Yes
 
View analytic
avatar for Andrew Campbell, M.D.

Andrew Campbell, M.D.

University of Michigan
Director, Pediatric Comprehensive Hemoglobinopathies Program Assistant Professor Department of Pediatrics Division of Pediatric Hematology/Oncology Co-Director, Minority International Research Training Program Center for Human Growth and Development

Dr. Campbell is a graduate of Case Western Reserve School of Medicine completed his residency training @ Harvard Affiliated Massachusetts General Hospital in Boston followed by Pediatric Hematology/Oncology Fellowship @ Northwestern University. Currently he directs the Comprehensive Pediatric Hemoglobinopathies Program which includes the Pediatric Sickle Cell and Thalassemia clinic @ the University of Michigan.  He is also Clinical Adjunct Professor in the Department of African Studies and a Faculty Associate for Global Reach Program @ the University of Michigan. He is Co-Investigator the NIH- Fogarty Funded Minority International Health Research Training Program (MHIRT) where his research has focused investigating the sickle cell phenotype  in the Ghanaian sickle cell patients including risk factors for pain crises, leg ulcers and renal disease. For the past several years he has focused his research in understanding the varied phenotypic expression of SCD in different populations through multinational CASiRe (Consortium for the Advancement of Sickle Cell Disease Research) International Consortium which he directs including—1) Europe- Italy (University of Padova, University of Naples), and UK (Guys St Thomas) 2) North America- USA: Univ of Michigan, Univ of Toledo-Promedica Toledo Children’s Hospital, University of Illinois Chicago, Univ of  Connecticut,  Albert Einstein-Montefiore,  Case Medical Center-Rainbow Children’s,  and 3) Africa- Ghana- Korle Bu Teaching Hospital, Princess Marie Louise Children’s Hospital.  The focus of the CASIRE Sickle Cell Research is the “ CASIRE Renal Cohort Study” where we are describing the risk factors associated with proteinuria in different SCD populations within different ethnic groups including people of African, Caribbean, Arab, American, and European descent. We are also studying the role of the environment on the phenotype of Sickle cell disease.